| Website | wellgen.com |
| Category | BioTech |
| Phone | 732-565-3890 |
| info@wellgen.com | |
| Employees |
| TOTAL | $12.5M |
| FUNDING TOTAL | $12.5M |
| Series B, 2/06 Amphion Innovations | $3M |
| Series C, 10/07 Amphion Innovations | $9.5M |
WellGen, Inc., based in North Brunswick, N.J., is a biotechnology company at the crossroads of foods and pharmaceuticals. Using the science of nutrigenomics, the company has developed Alignomx™, a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic areas for WellGen’s pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing proprietary medical foods and has additionally identified several opportunities in the functional food and beverage and dietary supplement markets. WellGen is a portfolio company of Amphion Innovations (LSE: AMP). For more information about WellGen, Inc., please see www.WellGen.com.
